On-Demand Webinar

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…

CertaraMay 6, 2026

On-Demand Webinar

Compliance? Anywhere, anytime: Automated controlled substance detection and tariff classification at Merck KGaA

Learn how Merck KGaA automates controlled substance detection and HS classification to ensure global compliance…

CertaraApril 27, 2026

On-Demand Webinar

Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access

Learn how model-informed strategies support ADC labeling, dose optimization, and market access through integrated evidence…

CertaraApril 10, 2026

On-Demand Webinar

Earning Regulatory Trust: Practical Strategies to Increase Model Acceptance in MIDD

Discover practical strategies to increase regulatory trust and acceptance of MIDD models, including PBPK and…

CertaraApril 6, 2026

On-Demand Webinar

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Watch this on-demand webinar to learn how the final ICH M15 guidance is shaping Model-Informed…

CertaraApril 2, 2026

On-Demand Webinar

Chemaxon presents: How Data Gaps Are Undermining Your Drug Discovery Decisions

Learn how leading R&D teams eliminate compound data gaps, improve traceability, and strengthen data integrity…

CertaraApril 2, 2026

On-Demand Webinar

Pinnacle 21 Community vs Enterprise: Watch the webinar to decide what’s right for your study

Watch the Pinnacle 21 Community vs Enterprise webinar to learn key considerations for validation approaches…

CertaraMarch 27, 2026

On-Demand Webinar

Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation

Learn how early-stage biosimulation and mechanistic modeling enable smarter portfolio prioritization before IND-enabling studies. Watch…

CertaraMarch 25, 2026

On-Demand Webinar

Right Dose, Right Regimen: Model-Informed Strategies for Antibody–Drug Conjugates (ADCs)

Watch this on-demand webinar to learn how model-informed strategies using PopPK, PBPK, and QSP can…

CertaraMarch 25, 2026

On-Demand Webinar

Leveraging the full potential of PBPK models to accelerate drug development

Explore how Novartis applies PBPK modeling in drug development using Simcyp to support regulatory decisions,…

CertaraMarch 20, 2026

On-Demand Webinar

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

Compliance? Anywhere, anytime: Automated controlled substance detection and tariff classification at Merck KGaA

Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access

Earning Regulatory Trust: Practical Strategies to Increase Model Acceptance in MIDD

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Chemaxon presents: How Data Gaps Are Undermining Your Drug Discovery Decisions

Pinnacle 21 Community vs Enterprise: Watch the webinar to decide what’s right for your study

Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation

Right Dose, Right Regimen: Model-Informed Strategies for Antibody–Drug Conjugates (ADCs)

Leveraging the full potential of PBPK models to accelerate drug development

Newsletter sign up

Quick links

Solutions

Contact